CompoAtlas

CPN Glucosamine with Chondroitin & MSM

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Sulfate de chondroïtine

Source : Bos taurus - cartilage

400 mgNot calculated
Sulfate de chondroïtine

Source : Sus scrofa (cartilage)

400 mgNot calculated
Sulfate de chondroïtine

Source : Gallus gallus - cartilage

400 mgNot calculated
Sulfate de 2-Amino-2-désoxy-D-glucose500 mgNot calculated
Harpagophytum procumbens

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 0.4 g

100 mgNot calculated
Méthylsulfonylméthane

Source : Sulfone de diméthyl

500 mgNot calculated

Non-medicinal ingredients

Amidon de maïs, Stéarate de magnésium, Gomme arabique, Phosphate dicalcique, Acide hyaluronique, Carboxyméthyl amidon de sodium, Curcuma

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years3 Comprimé1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

A factor in maintaining healthy cartilage and/or joint health. Helps to protect against the deterioration of cartilage. Helps to relieve (joint) pain associated with osteoarthritis (of the knee).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Canadian Pinnacle Nutritech Inc.
NPN or DIN-HM
80104489
Status
Active licence
Licence date
22 September 2020
Revision date
6 April 2021
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80104489

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Harpagophytum procumbens
    Read the warning, when it applies and the studies cited

    DEVIL'S CLAW - HARPAGOPHYTUM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 27 March 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Photograph the packaging

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “CPN Glucosamine with Chondroitin & MSM”, https://compoatlas.com/en/supplements/canada/80104489-cpn-glucosamine-with-chondroitin-msm, updated 6 April 2021.

List recorded in 2021. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line